Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 2,500 shares at $25.85 ($65K) on 2021-03-03, disclosed to the SEC on 2021-03-04.
Scheduled sale ($65k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 1,616 | $42K | 64.0% |
| 2 | $26.57 | 884 | $23K | 36.0% |
| Total | $26.10 avg | 2,500 | $65K | 100% |
| Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2021-01-06 | $140K | — | Filing → |
| BDTX | SELL | 2020-12-04 | $81K | — | Filing → |